Oramed Pharmaceuticals
ORMP
ORMP
19 hedge funds and large institutions have $11.1M invested in Oramed Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
74% less call options, than puts
Call options by funds: $70K | Put options by funds: $269K
Holders
19
Holding in Top 10
–
Calls
$70K
Puts
$269K
Top Buyers
| 1 | +$81.2K | |
| 2 | +$12.5K | |
| 3 | +$8K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$3K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$2K |
Top Sellers
| 1 | -$209K | |
| 2 | -$149K | |
| 3 | -$40.6K | |
| 4 |
Morgan Stanley
New York
|
-$33.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$29K |